Neuronetics, Inc — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/320daf19-ff48-4570-bc10-b6204b663b57/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-31.4M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-029004 |
| FY 2024 | $-34.6M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-003833 |
| FY 2023 | $-30.6M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002772 |
| FY 2022 | $-35.1M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-003044 |
| FY 2021 | $-27.6M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-003069 |
| FY 2020 | $-22.3M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-010320 |
| FY 2019 | $-26.9M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-008464 |
| FY 2018 | $-19.8M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006276 |
| FY 2017 | $-13.6M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-006276 |
| FY 2016 | $-9.3M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-006276 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).